Company Details
Sector | PHARMACEUTICALS |
Address | |
Auditor | |
Registrar | |
Website | |
Fiscal Year | |
Details |
Description
Company Announcements
Date/Time | Announcement |
---|---|
25/10/2024 16:20:06 | (UNCONSOLIDATED) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 5447.831 (UNCONSOLIDATED) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 3202.524 EPS = 27.36 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2024 DIVIDEND= 50% (i) BOOK CLOSURE FROM 07/11/2024 BOOK CLOSURE TO 08/11/2024 |
22/08/2024 16:51:09 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 1,872.740 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 3,209.018 EPS = 16.00 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2024 |
25/04/2024 16:27:35 | PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,117.512 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/12/2023 EPS = 5.55 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 649.281 |
05/03/2024 15:34:15 | BOOK CLOSURE TO 26/04/2024 BOOK CLOSURE FROM 19/04/2024 ANNUAL GENERAL MEETING WILL BE HELD ON 26/04/2024 EPS = 8.51 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 995.586 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,846.133 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2023 |
23/10/2023 16:08:12 | EPS = 5.36 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 627.355 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 1,243.835 FINANCIAL RESULT FOR THE NINE MONTHS ENDED 30/09/2023 |
22/08/2023 15:49:02 | PROFIT/LOSS AFTER TAXATION RS. IN MILLION 313.064 FINANCIAL RESULT FOR THE HALF YEAR ENDED 30/06/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 726.176 EPS = 2.67 |
02/05/2023 12:29:27 | EPS = 2.59 FINANCIAL RESULT FOR THE FIRST QUARTER ENDED 31/03/2023 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 468.104 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 303.139 |
15/03/2023 15:43:25 | BOOK CLOSURE TO 27/04/2023 BOOK CLOSURE FROM 20/04/2023 ANNUAL GENERAL MEETING HELD ON 27/04/2023 EPS = 2.78 PROFIT/LOSS AFTER TAXATION RS. IN MILLION 325.411 PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 992.791 FINANCIAL RESULT FOR THE YEAR ENDED 31/12/2022 |